Literature DB >> 17928924

Cell transformation and proteome alteration in QSG7701 cells transfected with hepatitis C virus non-structural protein 3.

Qiongqiong He1, Ruixue Cheng, Zhuchu Chen, Xuxian Xiao, Zhiqiang Xiao, Cui Li, Bo Li, Pengfei Zhang, Hui Zheng, Deyun Feng.   

Abstract

Persistent hepatitis C virus (HCV) infection can cause liver cirrhosis and hepatocellular carcinoma. Non-structural protein 3 (NS3), an important part of HCV, has been implicated in the life cycle of the virus and interacts with host cellular proteins. In this study, we investigated the effect of NS3 protein on cell tranformation and related protein alteration in human hepatocyte QSG7701 cells. The results indicated that stable expression of the NS3 protein in QSG7701 cells induced transformed characters with reduced population doubling time, anchorage-independent growth and tumor development. Fifteen differentially-expressed proteins were separated and identified using 2-D electrophoresis and matrix-assisted laser desorption ionization-time of flight mass spectrometry. Western blot analysis confirmed that the increase of phospho-p44/42 and phospho-p38 proteins was associated with transformed cells. These results supported the view that HCV NS3 protein plays a transforming role and provided some clues to elucidate the carcinogenesis mechanism of HCV-related hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17928924     DOI: 10.1111/j.1745-7270.2007.00344.x

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  2 in total

1.  Novel amino-modified silica nanoparticles as efficient vector for hepatocellular carcinoma gene therapy.

Authors:  Xuxian Xiao; Qiongqiong He; Kelong Huang
Journal:  Med Oncol       Date:  2009-12-01       Impact factor: 3.064

Review 2.  Hepatocarcinogenesis associated with hepatitis B, delta and C viruses.

Authors:  Elham Shirvani-Dastgerdi; Robert E Schwartz; Alexander Ploss
Journal:  Curr Opin Virol       Date:  2016-08-06       Impact factor: 7.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.